Nurix Therapeutics Inc. (NRIX) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Nurix Therapeutics Inc.

    NASDAQ: NRIX · Real-Time Price · USD
    9.38
    0.30 (3.30%)
    At close: Oct 03, 2025, 3:59 PM
    9.38
    0.00%
    After-hours: Oct 03, 2025, 05:55 PM EDT

    Nurix Therapeutics Balance Sheet Statement

    Financials in USD. Fiscal year is December - November.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Nov 30, 2024 Nov 30, 2023 Nov 30, 2022 Nov 30, 2021
    Cash & Equivalents
    		 110M 54.63M 64.47M 80.51M
    Short-Term Investments
    		 499.59M 233.28M 244.67M 215.21M
    Long-Term Investments
    		 901K 7.42M 63.88M 137.19M
    Other Long-Term Assets
    		 3.16M 4.72M 4.92M 3.12M
    Receivables
    		 1.5M 800K 1.1M 6.2M
    Inventory
    		 n/a n/a -1.1M n/a
    Other Current Assets
    		 8.3M 6.79M 9.31M 900K
    Total Current Assets
    		 619.39M 295.5M 318.45M 311.12M
    Property-Plant & Equipment
    		 45.9M 47.95M 29.51M 25.34M
    Goodwill & Intangibles
    		 n/a n/a -3.3M -3.33M
    Total Long-Term Assets
    		 49.96M 60.09M 98.31M 165.65M
    Total Assets
    		 669.34M 355.6M 416.76M 476.77M
    Account Payables
    		 11.48M 6.4M 5.06M 6.65M
    Deferred Revenue
    		 38.36M 48.1M 37.63M 41.21M
    Short-Term Debt
    		 n/a n/a 5.53M 3.85M
    Other Current Liabilities
    		 36.76M 751K 9.14M 5.67M
    Total Current Liabilities
    		 95.85M 86.96M 70.66M 66.26M
    Long-Term Debt
    		 n/a 23.13M 6.43M 9.19M
    Other Long-Term Liabilities
    		 n/a -23.13M -6.43M -9.19M
    Total Long-Term Liabilities
    		 46.5M 68.15M 42.41M 68.21M
    Total Liabilities
    		 142.35M 155.1M 113.06M 134.47M
    Total Debt
    		 28.3M 30.61M 11.96M 13.04M
    Book Value
    		 526.99M 200.49M 303.7M 342.3M
    Book Value Per Share
    		 7.85 3.69 6.25 7.98
    Common Stock
    		 76K 49K 47K 45K
    Retained Earnings
    		 -738.77M -545.2M -401.25M -220.89M
    Comprehensive Income
    		 150K -655K -4.32M -608K
    Shareholders Equity
    		 526.99M 200.49M 303.7M 342.3M
    Total Investments
    		 499.59M 240.7M 308.55M 352.4M

    Add to Watchlist